Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie - PubMed (original) (raw)

Affiliations

PMID: 1977959

Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie

A D Snow et al. Lab Invest. 1990 Nov.

Abstract

Previous histochemical studies have demonstrated highly sulfated glycosaminoglycans (GAGs) localized to the amyloid plaques in the brains of humans and animals with prion diseases (Snow et al., Acta Neuropathol 77:337, 1989). However, the identity of the specific class of proteoglycan/GAG present was not known. The current investigation used immunocytochemical techniques to identify and localize heparan sulfate proteoglycans (HSPGs) in human cases of Gerstmann-Straussler syndrome and Creutzfeldt-Jakob disease, as well as in experimental scrapie of hamsters. Polyclonal and monoclonal antibodies to either the protein core or GAG moiety of the basement membrane-derived HSPG were utilized. The results demonstrate that both the protein core and the GAG chains of HSPGs are immunolocalized to the prion protein amyloid plaques in each of these diseases. HSPG immunostaining was also evident in these tissues in blood vessels, choroid plexus, myelinated axons, and in the cytoplasm of certain neuronal and astrocytic populations, particularly those in close proximity to the amyloid plaques. Additionally, in Creutzfeldt-Jakob disease and Gerstmann-Straussler syndrome cerebellum, positive immunostaining for heparan sulfate GAGs was observed within the cell bodies of Purkinje cells. The specific accumulation of HSPGs in the amyloid deposits of both the prion diseases and Alzheimer's disease (Snow et al., Am J Pathol 133:456, 1988), suggests that a common mechanism involving HSPGs may occur in the pathogenesis of amyloidosis in each of these diseases.

PubMed Disclaimer

Cited by

The effect of glycosaminoglycans (GAGs) on amyloid aggregation and toxicity.
Iannuzzi C, Irace G, Sirangelo I. Iannuzzi C, et al. Molecules. 2015 Feb 2;20(2):2510-28. doi: 10.3390/molecules20022510. Molecules. 2015. PMID: 25648594 Free PMC article. Review.
Green fluorescent protein as a reporter of prion protein folding.
Vasiljevic S, Ren J, Yao Y, Dalton K, Adamson CS, Jones IM. Vasiljevic S, et al. Virol J. 2006 Aug 29;3:59. doi: 10.1186/1743-422X-3-59. Virol J. 2006. PMID: 16939649 Free PMC article.
Heparin Accelerates the Protein Aggregation via the Downhill Polymerization Mechanism: Multi-Spectroscopic Studies to Delineate the Implications on Proteinopathies.
Ahanger IA, Parray ZA, Nasreen K, Ahmad F, Hassan MI, Islam A, Sharma A. Ahanger IA, et al. ACS Omega. 2021 Jan 12;6(3):2328-2339. doi: 10.1021/acsomega.0c05638. eCollection 2021 Jan 26. ACS Omega. 2021. PMID: 33521471 Free PMC article.
The Apparent Organ-Specificity of Amyloidogenic ApoA-I Variants Is Linked to Tissue-Specific Extracellular Matrix Components.
Del Giudice R, Lindvall M, Nilsson O, Monti DM, Lagerstedt JO. Del Giudice R, et al. Int J Mol Sci. 2022 Dec 24;24(1):318. doi: 10.3390/ijms24010318. Int J Mol Sci. 2022. PMID: 36613763 Free PMC article.
Kinetic analysis of amyloid formation in the presence of heparan sulfate: faster unfolding and change of pathway.
Motamedi-Shad N, Monsellier E, Torrassa S, Relini A, Chiti F. Motamedi-Shad N, et al. J Biol Chem. 2009 Oct 23;284(43):29921-34. doi: 10.1074/jbc.M109.018747. Epub 2009 Aug 21. J Biol Chem. 2009. PMID: 19700762 Free PMC article.

Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie - PubMed (original) (raw)